Table 5a: Correlation of the mean items of the RAOS questionnaire with qualitative variables.
|
Pain |
Symptoms |
ADL |
Sport/Rec |
QOL |
|||||
|
Mean ± SD |
p |
Mean ± SD |
p |
Mean ± SD |
P |
Mean ± SD |
p |
Mean ± SD |
p |
Sex: male |
86.90 ± 15.69 |
0.03 |
84.18 ± 22.76 |
0.09 |
84.87 ± 17.24 |
0.11 |
65.00 ± 27.98 |
0.03 |
75.00 ± 27.38 |
0.04 |
Female |
65.17 ± 26.62 |
68.51 ± 24.06 |
69.18 ± 25.67 |
37.11 ± 34.24 |
48.91 ± 31.15 |
|||||
Clinical characteristics |
|
|||||||||
FR+ |
65.67 ± 26.75 |
0.52 |
68.92 ± 25.911 |
0.85 |
69.07 ± 25.05 |
0.4 |
38.59 ± 33.96 |
0.99 |
50.69 ± 31.98 |
0.74 |
FR- |
69.55 ± 26.70 |
68.92 ± 23.92 |
73.31 ± 27.03 |
38.54 ± 36.34 |
48.32 ± 31.10 |
|||||
ACPA+ |
66.48 ± 25.14 |
0.88 |
67.55 ± 24.29 |
0.66 |
68.74 ± 26.10 |
0.37 |
36.16 ± 34.40 |
0.18 |
49.12 ± 29.34 |
0.64 |
ACPA- |
67.41 ± 32.63 |
70.19 ± 27.75 |
74.38 ± 27.61 |
48.40 ± 38.50 |
52.75 ± 38.57 |
|||||
GC+ |
62.24 ± 27.34 |
< 0.01 |
65.22 ± 25.15 |
0.01 |
66.60 ± 26.26 |
< 0.01 |
34.78 ± 34.66 |
0.2 |
45.50 ± 31.99 |
0.07 |
GC- |
84.41 ± 14.79 |
83.33 ± 18.12 |
85.62 ± 15.63 |
49.12 ± 33.73 |
64.71 ± 26.32 |
|||||
CsDMARDs+ |
68.49 ± 26.39 |
0.12 |
71.60 ± 23.09 |
0.059 |
72.18 ± 24.86 |
0.08 |
41.16 ± 34.25 |
0.17 |
51.91 ± 30.72 |
0.32 |
csDAMRD- |
57.29 ± 31.12 |
59.15 ± 27.84 |
60.29 ± 26.84 |
28.00 ± 34.73 |
43.36 ± 35.09 |
|||||
b DMARD+ |
60.16 ± 27.45 |
0.06 |
61.38 ± 24.76 |
< 0.01 |
61.53 ± 26.37 |
< 0.01 |
24.83 ± 32.25 |
< 0.01 |
43.95 ± 33.46 |
0.144 |
b DAMRD- |
70.94 ± 25.59 |
74.84 ± 21.79 |
75.79 ± 22.97 |
46.80 ± 33.89 |
53.97 ± 30.23 |
|||||
Podiatric assessement |
|
|||||||||
Fore foot pain+ |
56.25 ± 23.78 |
< 0.001 |
61.90 ± 22.53 |
0.003 |
60.97 ± 22.93 |
0.001 |
28.83 ± 27.74 |
0.008 |
35.46 ± 23.09 |
<0.001 |
Fore foot pain- |
75.44 ± 25.57 |
76.41 ± 23.99 |
78.12 ± 24.977 |
46.98 ± 37.18 |
62.38 ± 31.25 |
|||||
Foot deformities+ |
65.42 ± 26.42 |
0.216 |
68.43 ± 24.23 |
0.211 |
69.03 ± 25.78 |
0.207 |
37.20 ± 34.73 |
0.164 |
48.53 ± 31.51 |
0.111 |
Foot deformities- |
75.21 ± 26.75 |
77.47 ± 23.34 |
78.62 ± 22.05 |
51.54 ± 31.23 |
63.46 ± 28.85 |
|||||
Synovitis of MTP and IPP joints of feet+ |
55.69 ± 22.68 |
0.038 |
63.75 ± 21.96 |
0.228 |
59.34 ± 22.66 |
0.031 |
15.50 ± 18.84 |
< 0.001 |
31.88 ± 19.54 |
0.003 |
Synovitis of MTP and IPP joints of feet- |
69.44 ± 26.84 |
71.07 ± 24.63 |
73.01 ± 25.47 |
45.26 ± 35.04 |
55.29 ± 32.21 |
|||||
Fibular tenosynovitis+ |
56.69 ± 20.89 |
0.021 |
62.70 ± 19.76 |
0.08 |
61.82 ± 21.21 |
0.042 |
22.22 ± 28.26 |
0.002 |
31.25 ± 19.76 |
0.001 |
Fibular tenosynovitis- |
70.40 ± 27.56 |
72.16 ± 25.28 |
73.41 ± 26.26 |
45.64 ± 34.61 |
57.83 ± 32.05 |
|||||
X-Ray |
|
|||||||||
Hallux valgus + |
65.86 ± 25.40 |
0.65 |
68.49 ± 23.67 |
0.48 |
69.40 ± 24.66 |
0.39 |
34.75 ± 32.78 |
0.11 |
46.62 ± 30.82 |
0.18 |
Hallux valgus - |
68.06 ± 28.59 |
71.43 ± 25.24 |
71.71 ± 26.54 |
45.92 ± 36.37 |
56.93 ± 31.82 |
|||||
Foot erosion+ |
64.18 ± 25.69 |
0.18 |
67.42 ± 24.44 |
0.26 |
66.43 ± 24.81 |
0.04 |
29.64 ± 30.86 |
0.002 |
45.34 ± 28.34 |
0.033 |
Foot erosion- |
71.9 ± 28.21 |
73.27 ± 24.35 |
77.23 ± 24.81 |
52.88 ± 35.81 |
59.82 ± 34.57 |
|||||
Erosion in the fifth metatarsal head in foot+ |
62.35 ± 25.55 |
0.051 |
67.14 ± 23.59 |
0.298 |
65.46 ± 25.21 |
0.05 |
24.20 ± 28.34 |
< 0.001 |
42.47 ± 27.07 |
0.006 |
Erosion in the fifth metatarsal head in foot- |
73.07 ± 26.03 |
72.52 ± 25.30 |
75.86 ± 24.72 |
53.18 ± 34.15 |
60.42 ± 32.64 |
|||||
Calcaneitis+ |
85.19 ± 8.4 |
0.24 |
75.00 ± 12.87 |
0.70 |
81.37 ± 23.90 |
0.49 |
66.67 ± 41.63 |
0.16 |
19.09 ± 11.02 |
0.73 |
Calcaneitis- |
67.24 ± 26.35 |
69.71 ± 24.24 |
71.62 ± 24.24 |
38.5 ± 34.31 |
52.08 ± 31.53 |
RAOS: Rheumatoid and Arthritis Outcome Score, ADL: Activities of Daily Living, Rec: Recreational ; BMI: Body Mass Index QOL: Quality Of Life, RF: rheumatoid factor (IU/ml); ACPA: anti-cyclic citrullinated peptide antibody; standard deviation ; HAQ: Health Assessment Questionnaire; DAS 28: Disease Activity Score 28; CRP: C reactive protein